Silodosin

Silodosin is a fluorinated benzimidazole derivative featuring a quinazoline core linked via an ester bridge to a piperidin-1-yl group. The molecule incorporates three trifluoromethyl substituents, an amide functionality, and a terminal propargyl chain. As the parent drug, it serves as a direct precursor for alpha-1A/1B adrenergic antagonist formulations. Its structural rigidity and electron-withdrawing fluorine atoms enhance metabolic stability. This compound functions as a key intermediate in the synthesis of targeted urological agents.